Stroke trials in China
352 of 489 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleThe Safety and Efficacy of NouvSoma001 in Ischemic Stroke
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 69
- Run by
- Wei Wang
See details and how to joinNCT06612710 - No phaseTaking peopleSecondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System
- Where
- Beijing, Shihezi
- Age
- 18 years and over
- People
- 4,490
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT06783049 - Phase 2Taking peopleThrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 340
- Run by
- Shanghai East Hospital
See details and how to joinNCT07279259 - Phase 2/3Taking peopleIntra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion
- Where
- Wuhan
- Age
- 18 years and over
- People
- 382
- Run by
- Xiang Luo
See details and how to joinNCT07302854 - No phaseTaking peopleIntensive Versus Conventional Blood Pressure Control Following Stroke Thrombectomy
- Where
- Suzhou
- Age
- 18 years and over
- People
- 910
- Run by
- Hao Yonggang
See details and how to joinNCT07350564 - Phase 3Not yet taking people in ChinaEptifibatide for Extended Window Ischemic Stroke After Thrombolysis
- Where
- Chongqing, Ganzhou, Haikou, Ji’an, Nanchang
- Age
- 18 years and over
- People
- 786
- Run by
- Xinqiao Hospital of Chongqing
See details and how to joinNCT07347626 - No phaseNot yet taking people in ChinaIAT-MeVO Trial Domain Within the ACT-GLOBAL Adaptive Platform Trial
- Where
- Chengdu
- Age
- 18 years and over
- People
- 614
- Run by
- Bo Wu
See details and how to joinNCT07336927 - Phase 3Not yet taking people in ChinaIntravenous Tirofiban After Bridging Therapy for Acute Stroke With Atherosclerotic Large Artery Occlusion
- Where
- Beijing
- Age
- 18 years and over
- People
- 564
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT07335107 - No phaseTaking peopleAngong Niuhuang Pills With Different Bovine Bezoar Formulation Sources in the Treatment of AIS
- Where
- Wuhan
- Age
- 18 years to 80 years
- People
- 100
- Run by
- Tongji Hospital
See details and how to joinNCT06883110 - No phaseNot yet taking people in ChinaThe Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core Infarction
- Where
- Beijing
- Age
- 18 years to 80 years
- People
- 308
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT07333950 - No phaseTaking peopleRAINBOW-ICH Trial of AI Guided Minimally Invasive Neurosurgery for ICH
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 1,000
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07205263 - Phase 3Taking peoplePhase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke
- Where
- Linfen
- Age
- 18 years to 80 years
- People
- 1,096
- Run by
- Shanghai Hutchison Pharmaceuticals Limited
See details and how to joinNCT07241520 - No phaseTaking peopleEffect of the Intelligent Lipid Management Decision-support System on 1-year LDL-C Target Achievement in Ischemic Stroke or TIA Patients Under Evolocumab Treatment in China
- Where
- Beijing
- Age
- 18 years and over
- People
- 4,000
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT07143149 - Phase 3Taking peopleIntravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window
- Where
- Jiujiang, Nanchang, Wuhan, Xiangtan
- Age
- 18 years and over
- People
- 820
- Run by
- Xinqiao Hospital of Chongqing
See details and how to joinNCT06987305 - No phaseTaking peopleEarly Tirofiban Administration After Intravenous Thrombolysis in Acute Ischemic Stroke
- Where
- Changchun
- Age
- 18 years and over
- People
- 1,084
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT06045156 - Phase 3Taking peopleCHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection
- Where
- Shanghai
- Age
- 18 years and over
- People
- 890
- Run by
- Huashan Hospital
See details and how to joinNCT06994975 - No phaseTaking peopleA Randomized Trial of Imaging Selection Modalities for Stroke Thrombectomy (NO-SELECT)
- Where
- Chongqing, Dalian, Haikou, Huai'an, Jiangmen, Jingdezhen, Wuhu, Wuxi
- Age
- 18 years and over
- People
- 1,846
- Run by
- Xinqiao Hospital of Chongqing
See details and how to joinNCT05230914 - No phaseTaking peopleEndovascular Treatment for eXtra-Large Ischemic Stroke
- Where
- Hengyang, Xiangtan
- Age
- 18 years and over
- People
- 286
- Run by
- Zhongming Qiu
See details and how to joinNCT06388148 - Phase 3Taking peopleEarly Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke
- Where
- Chifeng, Chuzhou, Dalian, Ganzhou, Huaihua, Huanggang, Ji’an, Jiujiang, Longyan, Nanchang, Nanning, Shaoyang, Songyuan, Xiangtan, Yichang, Yichun, Yingtan, Yueyang
- Age
- 18 years and over
- People
- 348
- Run by
- Second Affiliated Hospital of Guangxi Medical University
See details and how to joinNCT05604638 - Phase 4Taking peopleIntravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke
- Where
- Beijing
- Age
- 18 years and over
- People
- 976
- Run by
- Beijing Anzhen Hospital
See details and how to joinNCT07290751 - No phaseTaking peopleElectroacupuncture Treatment for Post-stroke Cognitive Impairment
- Where
- Hangzhou
- Age
- 35 years to 80 years
- People
- 340
- Run by
- Ruijie Ma
See details and how to joinNCT07208019 - Phase 3Taking peopleTenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 912
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07092709 - Phase 3Taking peoplePhase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.
- Where
- Puyang
- Age
- 18 years and over
- People
- 890
- Run by
- CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.
See details and how to joinNCT07201688 - Phase 2Taking peopleEfficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
- Where
- Anyang, Beijing, Cangzhou, Daqing, Datong, Hengshui, Jiaxing, Linfen, Linyi, Meihekou, Nanyang, Shenyang, Shenzhen, Tengzhou, Xianyang, Xuzhou
- Age
- 18 years to 80 years
- People
- 300
- Run by
- Kunming Pharmaceuticals, Inc.
See details and how to joinNCT07279493 - Phase 3Taking peopleNormobaric Oxygen in AIS Transferred for EVT
- Where
- Baoji, Beijing, Cangzhou, Dali, Dexing, Enshi, Fuzhou, Guangzhou, Handan, Hezhou, Huanggang, Ji’an, Jinzhong, Jiujiang, Kunming, Liaocheng, Lichuan, Lüliang, Luoyang, Lushancun, Mudanjiang, Nanchang, Ningde, Putian, Qujing, Shangrao, Tai’an, Taiyuan, Xuanwei, Yichun, Yima, Yingtan, Yuxi, Zhangshu, Zhangzhou, Zhoukou
- Age
- 18 years and over
- People
- 1,500
- Run by
- Capital Medical University
See details and how to joinNCT06666764